TrialAntimicrobial agents and chemotherapy2025

Phase 1, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the safety, tolerability, and pharmacokinetics of intravenous xeruborbactam (QPX7728) in healthy adult subjects.

María Patricia Hernández-Mitre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.